A Sjogrens Syndrome Diagnostic

Information

  • Research Project
  • 8593453
  • ApplicationId
    8593453
  • Core Project Number
    R21DE021854
  • Full Project Number
    7R21DE021854-03
  • Serial Number
    021854
  • FOA Number
    PA-10-069
  • Sub Project Id
  • Project Start Date
    8/1/2011 - 14 years ago
  • Project End Date
    7/31/2013 - 12 years ago
  • Program Officer Name
    BURGOON, PENNY W.
  • Budget Start Date
    8/17/2012 - 13 years ago
  • Budget End Date
    7/31/2013 - 12 years ago
  • Fiscal Year
    2012
  • Support Year
    03
  • Suffix
  • Award Notice Date
    12/7/2012 - 12 years ago
Organizations

A Sjogrens Syndrome Diagnostic

DESCRIPTION (provided by applicant): Sjgren's Syndrome (SS) is autoinflammatory condition, characterized by a plethora of symptoms, including dry eyes and mouth. Despite the fact that the condition is relatively common, with up to 3.1 million persons affected in the US, accurate diagnosis has been complex and largely ineffective. If left undiagnosed, and thus untreated, SS can progress to significant morbidity and increase the risk of certain forms of cancer up to 100 fold. The identification of SS patients is, therefore, a pressing unmet need. Current SS diagnostic tools have been limited, in part because of the wide range of symptoms and frequent overlap with other autoinflammatory disorders. In this study, we will use genome-wide expression profiling of peripheral blood leukocytes coupled with multivariate analysis to identify SS diagnostic biomarkers of disease. Our preliminary data support the hypothesis that such biomarkers can be identified that correctly classify patients and provide a powerful adjunct to current SS diagnostic methods. Our preliminary data demonstrate that a multi-variate gene expression-based algorithm has superior performance to distinguish among SS, rheumatoid arthritis (RA), and unaffected controls than current diagnostic laboratory tests. In this proposal, an algorithm will be developed utilizing a broader set of samples from additional common rheumatologic diseases within a standard SS differential. Multi-variate algorithm development will be done using state-of-the-art multi-variate statistics, utilizing adequately powered cohorts, and an iterative process of biomarker identification and verification though serial associative analyses in independent cohorts. Our group has utilized this general methodology to create multivariate biomarker algorithms highly correlated to clinical outcome, which have been translated into clinical laboratory tests.

IC Name
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
  • Activity
    R21
  • Administering IC
    DE
  • Application Type
    7
  • Direct Cost Amount
    75000
  • Indirect Cost Amount
    30000
  • Total Cost
    105000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    121
  • Ed Inst. Type
  • Funding ICs
    NIDCR:105000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ODCS
  • Study Section Name
    Oral, Dental and Craniofacial Sciences Study Section
  • Organization Name
    HAUS BIOCEUTICALS, INC.
  • Organization Department
  • Organization DUNS
    832128826
  • Organization City
    OKLAHOMA CITY
  • Organization State
    OK
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    731041232
  • Organization District
    UNITED STATES